HARVARD BIOSCIENCE INC — Director's Dealing 2025

Dec 30, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2025-12-17

Reporting Person: Snider William (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant (right to buy)	$0.50	2032-12-17	Common Stock (150000)		Indirect
Warrant (right to buy)	$0.50	2032-12-17	Common Stock (600000)		Indirect

Footnotes

F1: Held by BroadOak Fund VI, L.P. The reporting person is the Manager of BroadOak Fund VI, L.P. The reporting person disclaims beneficial ownership of the securities held by BroadOak Fund VI, L.P except to the extent of his pecuniary interest therein, if any.

F2: Held by BroadOak Income Fund, L.P. The reporting person is the Manager of BroadOak Income Fund, L.P. The reporting person disclaims beneficial ownership of the securities held by BroadOak Income Fund, L.P except to the extent of his pecuniary interest therein, if any.

F3: The Warrants are exercisable immediately. Notwithstanding the foregoing, the Reporting Person shall not be entitled to exercise the Warrants to the extent that such exercise would cause the aggregate number of shares of common stock of the Issuer, $0.01 par value per share (the "Common Stock"), beneficially owned by the Reporting Person to exceed 19.99% of the total number of outstanding shares of Common Stock following such exercise.